• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effects of brimonidine 0.2% on blue-yellow perimetry of glaucomatous patients.

作者信息

Mastropasqua L, Ciancaglini M, Carpineto P, Zuppardi E, Falconio G, Gallenga P E

机构信息

Institute of Ophthalmology, Gabriele D'Annunzio University, Chieti.

出版信息

Acta Ophthalmol Scand Suppl. 1998(227):36. doi: 10.1111/j.1600-0420.1998.tb00876.x.

DOI:10.1111/j.1600-0420.1998.tb00876.x
PMID:9972338
Abstract

A cross-over double-blind study was performed to evaluate the effect of acute administration of brimonidine on the blue-yellow perimetry. Thirty patients with primary open-angle glaucoma were admitted. After brimonidine administration, IOP and pupil diameter showed a significant reduction (p < 0.01) without modification in systolic and diastolic blood pressure. Blue-on-yellow perimetry showed a significant reduction in CPSD from 3.81 +/- 1.60 to 2.71 +/- 1.92 (p < 0.05). This result suggests that brimonidine improves ocular perfusion via a reduction of IOP.

摘要

相似文献

1
Effects of brimonidine 0.2% on blue-yellow perimetry of glaucomatous patients.
Acta Ophthalmol Scand Suppl. 1998(227):36. doi: 10.1111/j.1600-0420.1998.tb00876.x.
2
Ocular perfusion pressure and visual field indice modifications induced by alpha-agonist compound (clonidine 0.125%, apraclonidine 1.0% and brimonidine 0.2%) topical administration. An acute study on primary open-angle glaucoma patients.
Ophthalmologica. 2003 Jan-Feb;217(1):39-44. doi: 10.1159/000068249.
3
Changes in intraocular pressure and ocular perfusion pressure after latanoprost 0.005% or brimonidine tartrate 0.2% in normal-tension glaucoma patients.0.005%拉坦前列素或0.2%酒石酸溴莫尼定对正常眼压性青光眼患者眼压及眼灌注压的影响
Ophthalmology. 2002 Dec;109(12):2241-7. doi: 10.1016/s0161-6420(02)01247-2.
4
A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter clinical trial. Chronic Brimonidine Study Group.溴莫尼定每日两次治疗青光眼和高眼压症的1年研究。一项对照、随机、多中心临床试验。慢性溴莫尼定研究组。
Arch Ophthalmol. 1997 Jul;115(7):847-52. doi: 10.1001/archopht.1997.01100160017002.
5
Latanoprost and brimonidine: therapeutic and physiologic assessment before and after oral nonsteroidal anti-inflammatory therapy.拉坦前列素和溴莫尼定:口服非甾体抗炎治疗前后的治疗及生理评估
Am J Ophthalmol. 2002 Jan;133(1):11-8. doi: 10.1016/s0002-9394(01)01286-7.
6
Effects of acute topical administration of clonidine 0.125%, apraclonidine 1.0% and brimonidine 0.2% on visual field parameters and ocular perfusion pressure in patients with primary open-angle glaucoma.0.125%可乐定、1.0%阿可乐定和0.2%溴莫尼定急性局部给药对原发性开角型青光眼患者视野参数和眼灌注压的影响。
Acta Ophthalmol Scand Suppl. 2002;236:29-30. doi: 10.1034/j.1600-0420.80.s236.18.x.
7
Comparative acute effects of brimonidine 0.2% versus dorzolamide 2% combined with beta-blockers in glaucoma.0.2%溴莫尼定与2%多佐胺联合β受体阻滞剂治疗青光眼的急性对比效应
Graefes Arch Clin Exp Ophthalmol. 2000 Apr;238(4):302-5. doi: 10.1007/s004170050356.
8
A comparison of the short-term hypotensive effects and side effects of unilateral brimonidine and apraclonidine in patients with elevated intraocular pressure.单侧使用溴莫尼定和阿可乐定对眼压升高患者的短期降压效果及副作用比较。
Ophthalmologica. 2002 Jan-Feb;216(1):45-9. doi: 10.1159/000048296.
9
Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension. Brimonidine Study Group 2.一项正在进行的随机试验的12个月结果,该试验比较了0.2%酒石酸溴莫尼定和0.5%噻吗洛尔每日两次给药于青光眼或高眼压症患者的疗效。溴莫尼定研究组2。
Ophthalmology. 1998 Oct;105(10):1960-7. doi: 10.1016/s0161-6420(98)91048-x.
10
Brimonidine tartrate 0.2% twice daily vs timolol 0.5% twice daily: 1-year results in glaucoma patients. Brimonidine Study Group.酒石酸溴莫尼定0.2%每日两次与噻吗洛尔0.5%每日两次对比:青光眼患者的1年研究结果。溴莫尼定研究组
Am J Ophthalmol. 1999 Jan;127(1):20-6. doi: 10.1016/s0002-9394(98)00286-4.